Abstract
The genetic association of IL7R with several diseases, especially leukemia, qualifies it as a potential target for the development of therapies in conditions of uncontrolled cell proliferation and survival. Approximately 10% of childhood ALL have an oncogenic mutation in IL7Ra. We obtained murine anti-IL7R antibodies that recognize both the wild form (WT) and the mutated form of IL7R±, wh…